Drug Topics

JANUARY 15, 2025

The therapy is the first and only prefilled testosterone cypionate injection approved by the FDA.

FDA 469

FDA 469

STAT

JANUARY 15, 2025

Over the last week, companies developing artificial intelligence products for health care have announced a series of impressive fundraises that set the tone for what could be a banner year for AI investment. Timed to the J.P. Morgan Healthcare conference, the announcements include $245 million for Innovaccer, a health care data company that’s increasingly focused on AI, $141 million for Hippocratic AI, a company that develops generative AI agents to help with clinical tasks, and $105 mill

Hospitals 124

Hospitals 124

Drug Topics

JANUARY 15, 2025

There are a lack of data available on the optimal antiviral medication for nonsevere flu.

467

467

STAT

JANUARY 15, 2025

In May 2024 , nearly 90% of pharmacies were closed for a day as thousands of pharmacists protested over “over drug shortages, pharmacy closures and fears medications could be sold online, as well as higher pay.” More recently in November 2024 , pharmacy owners voted in favor of cutting hours and stopping home deliveries in a protest over funding.

132

132

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

PharmaVoice

JANUARY 15, 2025

CMS is expected to publish up to 15 drugs for the second cycle of the program by Feb. 1, and these are some of the drugs most likely to make the list.

259

259

STAT

JANUARY 15, 2025

SAN FRANCISCO — Are we entering a world in which all of the exciting new therapeutics come from China? That question and variations of it could be heard at coffee meetings and late-night cocktail parties this week during the J.P. Morgan Healthcare Conference.  Just days before planes full of biopharma executives and investors touched down in San Francisco, a flurry of companies launched with drug candidates from China.

142

142

The Checkup by Singlecare

JANUARY 15, 2025

If youre looking to reduce your body weight and body mass index (BMI), your healthcare provider may prescribe a GLP-1 medication, such as Wegovy (semaglutide), as part of your weight-loss program. However, due to a national shortage of Wegovy and Ozempic (the Type 2 diabetes treatment with the same active ingredient), patients are looking for alternatives.

Compounding 98

Compounding Compounding Pharmacies FDA Dosage 98

Drug Topics

JANUARY 15, 2025

A conversation with David Nau, PhD, professor of social and administrative pharmacy, and director of assessment at Ohio Northern University.

247

247

Pharmacy Times

JANUARY 15, 2025

Building on a previous report that revealed corrupt business practices among the big 3 PBMs, a second interim report finds that PBMs heightened prices for important specialty generic drugs to increase their profit margins.

139

139

Drug Topics

JANUARY 15, 2025

Sarah Gray, PharmD, GAICD, explored the unique combination of being both a pharmacist and nutritionist.

247

247

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

JANUARY 15, 2025

These drugs are set to revolutionize their respective disease states in 2025.

Community Pharmacies 139

Community Pharmacies 139

Fierce Healthcare

JANUARY 15, 2025

The new notice of proposed rulemaking adheres to calls from Congress and industry for the agency to create a special telemedicine registration system. Its three-tiered approach could cost telehealth companies over $40,000 to prescribe controlled substances in all 50 states.

Controlled Substances 137

Controlled Substances 137

PhRMA

JANUARY 15, 2025

This year at J.P. Morgan Healthcare Conference was one to remember.

130

130

Fierce Healthcare

JANUARY 15, 2025

The third day of the annual J.P. Morgan Healthcare Conference brings presentations from GoodRx, Health Catalyst, Talkspace and Salesforce along with Medicare Advantage insurers Alignment Healthcare and Clover Health.

Insurance 132

Insurance 132

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JANUARY 15, 2025

Posttraumatic stress disorder is found to be associated with coronary artery disease, hypertension, and heart failure.

105

105

Fierce Healthcare

JANUARY 15, 2025

Staffing shortages, administrative burdens and opportunities for technology are top of mind for behavioral health organizations, a new survey reveals.

110

110

pharmaphorum

JANUARY 15, 2025

Adverse events have led Keros to abandon a phase 2 trial of pulmonary arterial hypertension drug cibotacept, a would-be rival to MSD's Winrevair

105

105

STAT

JANUARY 15, 2025

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Yesterday, I read a dispassionate explanation in the New York Times of how to become a better swimmer. I’m already a proficient swimmer, so I knew all of the lessons. (Keep your head looking down , guys!) But it reminded me of a favorite personal essay , also in the Times.

Labelling 102

Labelling FDA 102

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

JANUARY 15, 2025

Experts think the current way of defining obesity based on BMI isn't nuanced enough to gauge health and the need for weight-loss therapies.

99

99

Pharmacy Times

JANUARY 15, 2025

Studies shows that Red Dye No. 3 was associated with tumor growth in male rats.

FDA 94

FDA 94

pharmaphorum

JANUARY 15, 2025

A new FTC report claims that pharmacy benefit managers generated $7.3bn by marking up specialty generics used to treat diseases like cancer and HIV.

97

97

Pharmacy Times

JANUARY 15, 2025

Radon is a tasteless, odorless radioactive gas associated with DNA damage and high genomic tumor instability.

94

94

pharmaphorum

JANUARY 15, 2025

Amgen's thyroid eye disease blockbuster Tepezza, given by infusion, is facing competition from an oral alternative from Sling Therapeutics

97

97

Fierce Healthcare

JANUARY 15, 2025

Consolidation's negative impact on prices, access and quality "were voiced vociferously by respondents," while private equity's influence on healthcare providers "seems to have struck a nerve in the public," federal agencies wrote in a new report.

82

82

pharmaphorum

JANUARY 15, 2025

Eli Lilly has revised its revenue forecast for 2024 after seeing weaker-than-expected growth for its diabetes and obesity therapies.

97

97

Fierce Healthcare

JANUARY 15, 2025

Federal departments said they'll continue allowing plans to calculate qualifying payment amounts using a "good faith, reasonable interpretation" of court rulings and prior guidance.

82

82

Pharmacy Times

JANUARY 15, 2025

The approach favors administration of frequent low-dose chemotherapy to reduce toxicities and optimize outcomes.

Chemotherapy 81

Chemotherapy 81

Fierce Healthcare

JANUARY 15, 2025

Changes to the Hart-Scott-Rodino Form finalized in October would increase the paperwork burden on merging entities and are set to go into effect Feb. 10.

77

77

Pharmacy Times

JANUARY 15, 2025

mRNA-1345 (mRESVIA; Moderna) has the potential to significantly transform the RSV disease state in 2025, according to data analysts.

Community Pharmacies 73

Community Pharmacies Vaccines 73

Fierce Healthcare

JANUARY 15, 2025

The HRSA-funded centers serve nearly 4.2 million people across the country. Each center will add an additional 20 hours of operation per week, on average, including early morning, night and weekend hours.

74

74

Pharmacy Times

JANUARY 15, 2025

Jim Dente of Advanced Pharmacy Solutions emphasizes the growing role of automation, artificial intelligence, and patient-centric business models in streamlining operations, improving patient care, and addressing industry challenges such as staff burnout and medication errors.

Patient Care 73

Patient Care 73

Fierce Healthcare

JANUARY 15, 2025

Self-funded Pennsylvania-based health plan Imagine360 is buying Ardent Healths third-party administrator (TPA) HealthFirst, the two companies revealed Jan. 15. | Alternative health plan Imagine360 is in buy mode, announcing it has acquired the former third-party administrator of Ardent Health system.

74

74

Pharmacy Times

JANUARY 15, 2025

Panelists discuss how hepatotoxicity risks vary among second-line primary biliary cholangitis (PBC) treatments, with seladelpar and elafibranor showing favorable hepatic safety profiles compared to obeticholic acid, though all require regular liver function monitoring and dose adjustments based on individual patient response and disease severity.

65

65